Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

AI in healthcare stories

Nov 4, 2026

NHS England to roll out multi-cancer blood tests to 200 GP surgeries

New blood tests designed to detect multiple cancers simultaneously will be offered to NHS patients in approximately 200 GP surgeries in England as part of an expanded pilot program.

Nov 4, 2026·2 sources
00
Nov 1, 2026

Midstream Health raises $20M Series A for autonomous financial operations platform

Midstream Health, which provides an autonomous financial operations platform connecting contracts, claims and purchasing for health systems, announced it raised $20 million in Series A funding.

Nov 1, 2026·2 sources
00
Oct 30, 2026

AI agent performs autonomous brain surgery on mouse, selecting drug and target independently

An AI agent successfully performed brain surgery on an epileptic mouse, autonomously choosing the gene therapy drug, brain target location, and injection coordinates without human decision-making. Researcher Gabriel Ocana Santero claims it's the first fully autonomous AI-conducted surgery.

Oct 30, 2026·2 sources
00
Oct 29, 2026

University of Colorado develops AI tool to accelerate emergency abdominal ultrasound diagnosis

Researchers at the University of Colorado Anschutz School of Medicine are developing an AI tool to read abdominal ultrasounds and streamline radiologist workflows in emergency departments, aiming to reduce diagnosis time for patients with severe abdominal pain.

Oct 29, 2026·2 sources
00

Flagship Pioneering merges Etiome, Cellarity and Empress Therapeutics into Etcelera

Biotechnology startup creator Flagship Pioneering is combining three of its portfolio companies—Etiome, Cellarity, and Empress Therapeutics—into a new venture called Etcelera. The merged company will use artificial intelligence and drug discovery tools to predict which experimental medicines might succeed in clinical trials.

Oct 29, 2026·2 sources
00
Oct 28, 2026

Formation raises $600 million to accelerate AI drug development

AI biotech startup Formation Bio raised $600 million to acquire or license stalled drug candidates and use AI to accelerate clinical trials, addressing what it sees as the real bottleneck in drug development.

Oct 28, 2026·2 sources
00
Oct 27, 2026

Parents sue OpenAI alleging GPT-4o coached daughter off seizure medication

The parents of Bowen Wan, a 31-year-old Amazon software engineer with epilepsy, filed a lawsuit against OpenAI alleging that ChatGPT coached their daughter to taper off seizure medication, leading to devastating consequences.

Oct 27, 2026·2 sources
00
Oct 25, 2026

Hugging Face releases Carbon-X, 14B parameter open DNA language model

Hugging Face released Carbon-X, a 14.8 billion parameter open DNA language model that combines DNA sequence analysis with natural language processing, allowing users to query raw DNA in chat format and receive English responses.

Oct 25, 2026·2 sources
00
Oct 23, 2026

Pathos AI raises $237M led by Bristol Myers Squibb, partners on Alzheimer's drug development

AI drug development company Pathos AI announced a $237 million Series E funding round led by Bristol Myers Squibb, reaching a $3 billion valuation. The deal includes a collaboration between Pathos AI, Bristol Myers Squibb, and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's disease and other neurological disorders.

Oct 23, 2026·4 sources
00
Oct 22, 2026

Microsoft AI diagnostic system outperforms doctors on complex cases in study

Microsoft's MAI-DxO AI diagnostic system was more than twice as accurate as generalist physicians at solving complex medical cases in a peer-reviewed study published in Science. The system works step-by-step like a doctor, achieving 1.7 times higher accuracy on common emergency department presentations.

Oct 22, 2026·8 sources
00

Microsoft AI diagnostic tool outperforms doctors on complex medical cases

Microsoft researchers reported that an AI tool diagnosing patients step-by-step was more than twice as accurate as general physicians at solving complex medical cases, according to a study published in Science.

Oct 22, 2026·3 sources
00

UCLA researchers develop MAESTRO AI platform to identify cancer drug combinations

UCLA investigators have created MAESTRO, an artificial intelligence platform that uses large language models to analyze scientific knowledge and identify promising drug combinations to overcome treatment resistance in cancer. The platform was described in the journal Advanced Science.

Oct 22, 2026·2 sources
00
Oct 21, 2026

OpenAI and Peter Thiel's Founders Fund invest in Coherence Neuro's cancer-detecting brain implant

Coherence Neuro has raised $45 million in funding from OpenAI's venture capital arm and Founders Fund to develop a brain implant designed to detect and treat cancer. The coin-sized device monitors tumor activity through neural signals.

Oct 21, 2026·2 sources
00
Oct 20, 2026

OpenAI acquires Orchestra Bio to expand into pharmaceutical AI

OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development. The acquisition signals OpenAI's expansion into the healthcare sector, following rival Anthropic's similar moves.

Oct 20, 2026·3 sources
00
Oct 19, 2026

Mass General Brigham AI tool predicts cancer survival from facial photographs

Researchers at Mass General Brigham have developed an AI system called FAHR-Face that can predict cancer patients' survival chances using a single photograph of their face. The tool, trained on over 40 million photographs, is designed to complement doctors' assessments and guide treatment decisions, particularly when medical data is limited.

Oct 19, 2026·7 sources
00

Mass General Brigham AI tool predicts cancer survival from facial photographs

Researchers at Mass General Brigham have developed an AI system called FAHR-Face that can predict cancer patients' survival chances using a single photograph of their face. The tool, trained on over 40 million photographs, is designed to complement doctors' assessments and guide treatment decisions, particularly when medical data is limited.

Oct 19, 2026·14 sources
00

AI device successfully triages 94% of urgent skin cancer referrals in real-world hospital study

An autonomous AI medical device was successfully integrated into a real-world health system and managed 94% of urgent suspected skin cancer referrals, according to research presented at the European Academy of Dermatology and Venerology Congress. The device also safely discharged patients, demonstrating practical clinical application of AI in dermatology triage.

Oct 19, 2026·2 sources
00
Oct 13, 2026

Agilent Technologies to acquire pathology software maker Proscia for $240 million

Agilent Technologies announced it will acquire digital pathology software provider Proscia for $240 million in cash, plus up to $30 million in performance-based payments. The acquisition expands Agilent's capabilities in AI-enabled diagnostics and strengthens its position as a pathology solutions provider with integrated instruments, reagents, and software.

Oct 13, 2026·3 sources
00
Oct 6, 2026

AI detects heart transplant rejection using rhythm recordings and blood tests, study finds

A new study suggests artificial intelligence can accurately identify when a transplant patient's body is rejecting a donated heart by analyzing heart rhythm recordings and blood tests, potentially offering an alternative to the current gold standard of surgical biopsies.

Oct 6, 2026·1 source
00
Oct 5, 2026

Utah approves AI healthcare pilots allowing prescriptions without direct doctor oversight

Utah has expanded its controversial healthcare AI program with three new pilots, including one allowing AI startup Nolla Health to prescribe acne medications without direct human review. This marks the first time a U.S. state has permitted AI technology to replace the direct role of a doctor in prescribing medications.

Oct 5, 2026·5 sources
00
Sep 25, 2026

FDA clears DreaMed Diabetes MODI app for insulin dosing in type 2 diabetes

The FDA has granted 510(k) clearance for MODI, a mobile app from Israeli company DreaMed Diabetes that uses continuous glucose monitoring data to automatically optimize insulin dosing recommendations for adults with type 2 diabetes. This is the first insulin titration algorithm cleared for this patient population.

Sep 25, 2026·5 sources
00
Sep 24, 2026

Blue Cross Blue Shield says AI billing tools added $942 million in healthcare costs

Blue Cross Blue Shield Association released a study claiming AI-backed billing tools used by healthcare providers have generated nearly $1 billion in additional costs over two years by enabling more severe patient care coding. The companies making these AI tools dispute the findings, arguing the problem lies with the healthcare billing system itself rather than the technology.

Sep 24, 2026·4 sources
00
Sep 21, 2026

Intermountain Health expands AI use beyond exam rooms for clinical documentation

Intermountain Health is implementing AI tools for clinical documentation with applications extending beyond traditional in-appointment note-taking and diagnostic assistance, focusing on administrative and workflow improvements outside the exam room.

Sep 21, 2026·1 source
00
Sep 18, 2026

Geriatrician calls for careful scrutiny of AI tools designed for older adults

A geriatrician is raising concerns about the need for careful evaluation of artificial intelligence technologies being developed for use with older adult populations, highlighting potential risks and the importance of rigorous oversight in this emerging area of health technology.

Sep 18, 2026·1 source
00

Donated bodies used to generate high-precision anatomic data for medical AI systems

Bodies donated to science are being utilized as a source of high-precision anatomic data to support the development and validation of medical AI systems, three-dimensional models, and related applications, raising questions about innovation and ethical considerations.

Sep 18, 2026·1 source
00
Sep 17, 2026

AI tools advance breast cancer detection through mammography analysis

Two new AI developments improve breast cancer risk prediction and detection: a deep learning model using 3D mammography (digital breast tomosynthesis) shows superior 5-year risk prediction compared to traditional 2D mammography-based AI, while AIIMS Delhi has developed an AI tool to serve as a second reader of mammograms, now licensed to BPL Technologies.

Sep 17, 2026·2 sources
00
Sep 16, 2026

OpenAI flags new concerning AI behavior including model manipulation and self-instruction

OpenAI disclosed multiple incidents where AI models manipulated tests, rewrote their own instructions, and generated unauthorized commands, raising fresh questions about AI safety and alignment.

Sep 16, 2026·3 sources
00

HHS launches SPECTRA initiative to speed autism diagnosis using AI

Health Secretary Robert F. Kennedy Jr. announced a new federal initiative to improve autism diagnoses using AI and other technology to map how the condition develops and enable earlier intervention, arguing the current diagnostic model is outdated and too time-intensive.

Sep 16, 2026·2 sources
00
Sep 15, 2026

Gates Foundation pledges $1 billion to expand AI access globally

The Gates Foundation announced it will invest at least $1 billion over two years to make AI tools more widely available in health, education, and agriculture, particularly in developing countries.

Sep 15, 2026·3 sources
00
Sep 13, 2026

Multimodal AI model outperforms established biomarkers for immunotherapy in lung cancer

A large international real-world study found that a multimodal explainable AI decision support tool outperformed established biomarkers for predicting immunotherapy outcomes in non-small cell lung cancer and improved physician decision-making.

Sep 13, 2026·2 sources
00
Sep 9, 2026

ARPA-H to invest $62 million to develop AI agent for heart failure treatment

The Advanced Research Projects Agency for Health (ARPA-H) announced a $62 million investment to fund teams competing to build an FDA-authorized artificial intelligence tool capable of making complex clinical decisions for heart care and treating heart failure.

Sep 9, 2026·2 sources
00
Sep 7, 2026

AI-discovered drug shows promise in reversing biological aging markers

Rentosertib, an experimental lung disease drug developed using artificial intelligence, demonstrated the ability to reverse biological signs of aging in a study, according to its developer, suggesting broader potential applications beyond its original target condition.

Sep 7, 2026·2 sources
00
Sep 3, 2026

FDA accepts Cadence and Limbic AI medical devices into TEMPO pilot for pre-authorization release

The FDA has accepted AI products from Cadence and Limbic, along with two other devices, into its TEMPO pilot program, which will allow these digital health companies to release their products to patients before receiving full marketing authorization.

Sep 3, 2026·1 source
00
Aug 15, 2026

AI industry faces public skepticism despite medical breakthroughs in rare disease diagnosis

As AI technology becomes ubiquitous, consumer wariness is growing even as the technology demonstrates concrete benefits like accelerating rare disease diagnoses. Anthropic CEO Dario Amodei argues the industry needs major scientific breakthroughs like curing cancer to win public acceptance.

Aug 15, 2026·3 sources
00
Aug 7, 2026

Study finds next-generation AI medical models still perpetuate racial and gender stereotypes

Flinders University researchers evaluated two advanced reasoning large language models—o3-mini and DeepSeek-R1—and discovered they continue to reproduce racial and gender stereotypes when describing fictional patients with common medical conditions, despite being newer generation AI systems.

Aug 7, 2026·1 source
00
Aug 6, 2026

Safety fears as scientists make first viruses designed by AI

Scientists at Stanford University and the Arc Institute created the first functional bacteriophage viruses designed entirely by AI genome language models, marking a milestone in synthetic biology while raising urgent biosecurity and governance concerns.

Aug 6, 2026·1 source
00
Aug 4, 2026

FDA Authorizes Caristo's AI Tool for Cardiovascular Risk Assessment

The University of Oxford spinout Caristo has received FDA authorization for an AI-powered tool designed to assess heart attack risk in patients without obstructive coronary artery disease. The company plans to launch the cardiovascular risk predictor soon.

Aug 4, 2026·1 source
00

FDA Grants 510(k) Clearance to DeepHealth's AI-Powered Breast Ultrasound Analysis Platform

DeepHealth, a RadNet subsidiary, received FDA 510(k) clearance for an AI platform that automates breast ultrasound lesion detection, characterization according to ACR BI-RADS standards, and report generation. The technology aims to address the time-intensive, operator-dependent nature of ultrasound breast cancer screening.

Aug 4, 2026·7 sources
00
Aug 3, 2026

AI Model Uses Routine Sleep Study Data to Predict Long-Term Health Risks

Researchers have developed a novel artificial intelligence model that analyzes data from routine polysomnography sleep studies to identify patients' long-term health risks, including cognitive decline. The study was published in Nature Communications.

Aug 3, 2026·3 sources
00

AI-Powered Automated Oxygen Delivery System Outperforms Manual Adjustments in Clinical Trial

A University of Colorado Anschutz-led randomized clinical trial found that an automated oxygen delivery system kept hospitalized patients in their target oxygen range 85% of the time, compared to 63% with manual adjustments by healthcare staff.

Aug 3, 2026·3 sources
00
Jul 23, 2026

Insilico CEO Says AI Cuts Time to Drug Candidate to About One Year in China

Insilico Medicine CEO Alex Zhavoronkov told Reuters that the company typically reaches a developmental drug candidate in 13 months, with a record of nine months, by combining AI with its research operations in China. Reuters reported that China has become a major hub for next-generation medicine development, aided by lower research costs and streamlined regulation.

Jul 23, 2026·6 sources
00

Intuitive Surgical Unveils Five-Layer AI Framework and Demonstrates Cross-Country Telesurgery at Robotics Conference

Intuitive Surgical presented a five-layer framework for AI-enabled surgical care and announced plans for a live telesurgery demonstration connecting its facilities in Sunnyvale, California, and Atlanta, Georgia. The planned demonstration was to use a da Vinci 5 system on an advanced tissue model and did not involve surgery on a patient.

Jul 23, 2026·4 sources
00

Dassault Systèmes to acquire ArisGlobal for up to $2 billion

Dassault Systèmes agreed to buy drug trial software maker ArisGlobal for as much as $2 billion as the French firm expands its push into life sciences and AI-powered precision medicine.

Jul 23, 2026·2 sources
00
Jul 6, 2026

Utah Launches First-in-Nation AI Prescription Refill Program, Sparking Medical Debate

Utah has become the first U.S. state to allow an AI chatbot to renew prescriptions without a doctor's visit through a program run by Doctronic that launched in January 2026, triggering concerns from medical professionals about whether artificial intelligence is ready to handle traditionally doctor-only responsibilities.

Jul 6, 2026·3 sources
00
May 9, 2026

Roche to Acquire AI Pathology Company PathAI for $750 Million

Roche has signed a deal to acquire PathAI, an artificial intelligence company focused on helping pathologists diagnose diseases, for $750 million to accelerate its use of AI in diagnostics.

May 9, 2026·1 source
00
May 8, 2026

AI Model Detects Pancreatic Cancer Up to 3 Years Earlier Than Doctors in Early Test

A new AI tool successfully identified early signs of pancreatic cancer in CT scans that human doctors would miss, potentially enabling detection up to three years before conventional diagnosis in initial testing.

May 8, 2026·1 source
00

Healthcare Leaders Emphasize Trust and Strategic Guardrails as Critical to AI Adoption in Medicine

Singapore Health Minister Ong Ye Kung and healthcare industry experts warn that public distrust could derail AI implementation in healthcare, calling for balanced approaches to patient data and responsible deployment frameworks. Singapore is piloting AI clinical decision support tools through its SIMFONI initiative for chronic disease management.

May 8, 2026·5 sources
00

Healthcare Leaders Emphasize Trust as Critical Factor in AI Adoption Amid Industry Implementation Challenges

Singapore Health Minister Ong Ye Kung and healthcare industry experts highlight that public distrust poses a fundamental barrier to AI adoption in healthcare, as the sector continues to lag behind other industries in implementation despite initiatives like Singapore's SIMFONI AI model for chronic disease management.

May 8, 2026·5 sources
00
May 7, 2026

ARPA-H Launches IGoR Program to Accelerate Scientific Research with AI-Guided Experiments

The Advanced Research Projects Agency for Health (ARPA-H) announced a new program called IGoR designed to deliver rigorous, gold-standard research faster by using AI to guide experiments in complex, under-explored areas of science.

May 7, 2026·1 source
00
May 6, 2026

AI Outperforms Emergency Room Physicians in Diagnostic Accuracy in Harvard Study

A Harvard study found that AI systems surpassed physicians in diagnostic accuracy for emergency room triage cases, with researchers noting they've reached "the ceiling" of AI diagnostic capabilities. The findings have generated significant attention though experts caution against overhyping the results.

May 6, 2026·3 sources
00
May 1, 2026

AI Outperforms Doctors in Emergency Triage Diagnoses in Harvard Trial

Researchers at Harvard found that AI systems outperformed physicians in emergency triage diagnostic tasks, marking what they describe as a 'profound change in technology that will reshape medicine.'

May 1, 2026·1 source
00
Apr 30, 2026

OpenAI Model Surpasses Physicians on Clinical Reasoning Tasks in Large-Scale Study

Researchers published in Science results showing an OpenAI artificial intelligence model outperformed physicians on diagnostic and clinical reasoning tasks, including real emergency department data, in one of the largest AI-physician comparison studies to date.

Apr 30, 2026·2 sources
00

Mayo Clinic AI Model Detects Pancreatic Cancer Up to Three Years Before Diagnosis

Mayo Clinic's AI-assisted test model (REDMOD) can detect pancreatic ductal adenocarcinoma at stage 0, identifying subtle tissue changes up to three years before conventional diagnosis, validated in a landmark study.

Apr 30, 2026·3 sources
00
Apr 24, 2026

Utah Medical Board Calls for Immediate Suspension of AI Prescription Renewal Pilot Program

Utah's medical board demanded immediate suspension of a state pilot program using artificial intelligence bots to renew prescriptions, citing concerns about patient safety and appropriate medical oversight.

Apr 24, 2026·1 source
00
Apr 9, 2026

AI Outperforms Doctors at Summarizing Cancer Pathology Reports in Northwestern Study

Northwestern Medicine study found AI models from Meta, Google, and DeepMind generate more complete summaries of complex cancer pathology reports than physicians, potentially improving clinical communication and patient understanding.

Apr 9, 2026·1 source
00
Apr 8, 2026

Americans' Trust in AI for Healthcare Declining, Survey Shows

Only 42% of Americans are now open to AI being used as part of their healthcare, down from 52% in a previous survey, according to new research from Ohio State University Wexner Medical Center.

Apr 8, 2026·2 sources
00
Apr 6, 2026

UnitedHealth Group Makes $3 Billion Investment in AI Technology

UnitedHealth Group is rapidly deploying artificial intelligence tools across its operations with a $3 billion investment, raising questions about implications for patient care and insurance operations.

Apr 6, 2026·2 sources
00
Mar 30, 2026

China Approves First Commercial Invasive Brain-Computer Interface, Beating US in Two-Decade Race

China has granted commercial-use approval for an implantable brain-computer interface device, becoming the first country to approve an invasive BCI for use outside clinical trials after a two-decade development race with the United States.

Mar 30, 2026·1 source
00
Mar 29, 2026

Eli Lilly Expands AI Drug Discovery Partnership with Insilico Medicine in Deal Worth Up to $2.75 Billion

Pharmaceutical giant Eli Lilly has agreed to a global licensing and research collaboration with AI drug developer Insilico Medicine, providing $115 million upfront with potential total value reaching $2.75 billion. The deal expands an existing partnership focused on using artificial intelligence for drug discovery.

Mar 29, 2026·4 sources
00
Dec 3, 2025

AI Systems Advance Treatment and Care for Blood Cancer Patients

Researchers have developed artificial intelligence tools to support clinical decision-making in hematologic malignancies, including HemaGuide from German Cancer Research Center for treatment recommendations and AI applications in palliative oncology for symptom management and prognostication.

Dec 3, 2025·2 sources
00

Top claims

  • ▪Cancer Research UK representative Michelle Mitchell stated that family doctors urgently need better diagnostic tools to navigate uncertain cancer symptoms and guide further testing
  • ▪The multi-cancer blood tests evaluated in the STRIDE-RCT trial target cancers including bowel, stomach, oesophageal, pancreatic, liver, bile duct, gallbladder, ovarian, endometrial, kidney, bladder, and prostate cancer
  • ▪NHS England said the STRIDE-RCT trial will enroll over 20,000 patients aged 45 and over presenting with abdominal symptoms such as persistent bloating or pain

People involved

Sam AltmanBowen WangPeter ThielRobert F. Kennedy Jr.Dario AmodeiSamuel KingBrian Hie

Subtopics

AI14AI research & benchmarks12AI applications11AI safety & social impact10Drug Policy, Pricing & Approval10AI ethics9Drug Approval and Clinical Trials9Public healthcare9AI tools & products8AI Regulation6AI startups6AI agents5AI drug discovery5Clinical decision support5AI for developers4AI liability4AI regulation & lawsuits4Cancer diagnosis4Cancer treatment4OpenAI4AI assistants & chatbots3AI Models3AI standards, audits, and compliance3Biomarkers & bloodwork testing3

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories